EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   3.1.11.1 | Hypersensitivity |
1702127 |
1,25-Dihydroxyvitamin D3 potentiates the decreased response of lymphocytes from atopic subjects to agents that increase intracellular cyclic adenosine monophosphate. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 3.1.11.1 | Dermatitis, Atopic |
28290219 |
2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
4
0 |
| 3.1.11.1 | Hypertension, Pulmonary |
19203474 |
3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
4
0 |
| 3.1.11.1 | Neoplasms |
177749 |
5'-nucleotide phosphodiesterase activity of floxuridine-resistant mouse glioma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
2
4
1 |
| 3.1.11.1 | Whooping Cough |
8793911 |
5-HT1A receptor-mediated inhibition of acetylcholine release from guinea pig myenteric plexus: potential mechanisms. |
ongoing research
therapeutic application
unassigned |
2
2
0 |
| 3.1.11.1 | Cholera |
8190100 |
5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. |
therapeutic application
unassigned |
1
0 |
| 3.1.11.1 | Asthma |
16470317 |
<a name="home"></a>Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
4
4
0 |
| 3.1.11.1 | Pulmonary Disease, Chronic Obstructive |
17640111 |
A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease. |
therapeutic application
unassigned |
4
0 |
| 3.1.11.1 | Erectile Dysfunction |
34409246 |
A case report of pudendal arteries angioplasty with sirolimus drug-coated balloon and drug-eluting stent associated with intracavernous autologous peripheral blood mononuclear cells injection for untreatable vasculogenic erectile dysfunction. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.1.11.1 | Asthma |
11429372 |
A comparison of the relaxant effects of olprinone and aminophylline on methacholine-induced bronchoconstriction in dogs. |
therapeutic application
unassigned |
4
0 |
